Here's Why Cronos Still Isn't a Buy, Despite Posting a Profit and Boasting $1 Billion in Cash
Cannabis investors sometimes have to take earnings results with a grain of salt. Relying just on sales and net income figures can lead to incorrect conclusions. Cronos has recorded a positive net income figure in each of its past five quarterly results.